The reported statements, read against the company's own industry.
Financials view
Market Capitalization
412.27MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue (TTM)
63.30MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Profit Margin
-57.42%
vs Health Information Services peers
Updated Sep 27, 2026
52-Week Change
12.27%
vs all stocks
Updated Sep 27, 2026
Market Capitalization
412.27MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Enterprise Value
344.96MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Forward P/E
-10.94x
vs Health Information Services peers
Updated Sep 27, 2026
Price to Sales (TTM)
6.51x
vs Health Information Services peers
Updated Sep 27, 2026
Price to Book (MRQ)
4.88x
vs Health Information Services peers
Updated Sep 27, 2026
Enterprise to Revenue
5.45x
vs Health Information Services peers
Updated Sep 27, 2026
Enterprise to EBITDA
-9.02x
vs Health Information Services peers
Updated Sep 27, 2026
Gross Margin
76.78%
vs Health Information Services peers
Updated Sep 27, 2026
Profit Margin
-57.42%
vs Health Information Services peers
Updated Sep 27, 2026
Operating Margin
-58.27%
vs Health Information Services peers
Updated Sep 27, 2026
Return on Assets (TTM)
-28.19%
vs Health Information Services peers
Updated Sep 27, 2026
Return on Equity (TTM)
-66.14%
vs Health Information Services peers
Updated Sep 27, 2026
Revenue (TTM)
63.30MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue per Share (TTM)
2.48USDUpdated Sep 27, 2026
Quarterly Revenue Growth
56.70%
vs Health Information Services peers
Updated Sep 27, 2026
Gross Profit (TTM)
48.50MUSD
vs all stocks (USD)
Updated Sep 27, 2026
EBITDA (TTM)
-38.26MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Net Income (TTM)
-36.34MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Quarterly Earnings Growth (YoY)
56.75%
vs Health Information Services peers
Updated Sep 27, 2026
Operating Cash Flow (TTM)
-34.15MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Levered Free Cash Flow (TTM)
-26.41MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 27, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Sep 27, 2026
Revenue
50.51MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
12.47MUSDFY2025 · Dec 31, 2025
Gross Profit
38.04MUSDFY2025 · Dec 31, 2025
Operating Income
-30.57MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-29.63MUSDFY2025 · Dec 31, 2025
Net Income
-29.63MUSDFY2025 · Dec 31, 2025
EBIT
-28.20MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-27.59MUSDFY2025 · Dec 31, 2025
Research & Development
17.02MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
51.59MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
2.70MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.43MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-2.12USDFY2025 · Dec 31, 2025
EPS (Diluted)
-2.12USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
14.22MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
14.22MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-29.63MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-32.33MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-32.98MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
85.89MUSDFY2025 · Dec 31, 2025
Interest Paid
1.20MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-29.63MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
281.00KUSDFY2025 · Dec 31, 2025
Stock-based Compensation
1.93MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
759.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-5.01MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
2.32MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-2.98MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-642.00KUSDFY2025 · Dec 31, 2025
Purchase of Investments
-24.00MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-126.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-24.77MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-5.46MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
99.92MUSDFY2025 · Dec 31, 2025
Shares Outstanding
27.27MSharesUpdated Sep 27, 2026
Float Shares
15.65MSharesUpdated Sep 27, 2026
Shares Short
1.08MSharesUpdated Sep 27, 2026
Short Ratio
7.76days
vs all stocks
Updated Sep 27, 2026
Short % of Shares Outstanding
10.55%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 3.96%.Updated Sep 27, 2026
% Held by Insiders
44.51%
vs all stocks
Updated Sep 27, 2026
% Held by Institutions
40.37%
vs all stocks
Updated Sep 27, 2026
Total Cash (MRQ)
89.22MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Cash per Share (MRQ)
3.27USDUpdated Sep 27, 2026
Total Debt (MRQ)
21.92MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Debt to Equity (MRQ)
0.2601x
vs Health Information Services peers
Updated Sep 27, 2026
Current Ratio (MRQ)
8.84x
vs Health Information Services peers
Updated Sep 27, 2026
Book Value per Share (MRQ)
3.09USDUpdated Sep 27, 2026
Total Assets
130.12MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
126.67MUSDFY2025 · Dec 31, 2025
Total Liabilities
31.25MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.45MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
16.97MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
14.28MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
85.79MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
24.00MUSDFY2025 · Dec 31, 2025
Accounts Receivable
11.36MUSDFY2025 · Dec 31, 2025
Inventory
1.84MUSDFY2025 · Dec 31, 2025
Accounts Payable
4.48MUSDFY2025 · Dec 31, 2025
Short-term Debt
752.00KUSDFY2025 · Dec 31, 2025
Long-term Debt
16.66MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
309.00KUSDFY2025 · Dec 31, 2025
Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025
Retained Earnings
-100.81MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
98.87MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
8.50USDUpdated Sep 27, 2026
52-Week High
17.23USDUpdated Sep 27, 2026
52-Week Change
12.27%
vs all stocks
Updated Sep 27, 2026
50-Day MA
14.34USDUpdated Sep 27, 2026
200-Day MA
12.22USDUpdated Sep 27, 2026
Avg 10-Day Volume
81.70KSharesUpdated Sep 27, 2026
Avg 30-Day Volume
121.80KSharesUpdated Sep 27, 2026
Diluted EPS (TTM)
-2.34USDUpdated Sep 27, 2026
Other Income / Expense
-328.00KUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable